BARCELONA, Spain, Feb. 4, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Servier will adopt Veeva RIM to unify its global regulatory operations. By bringing regulatory processes ...

Servier has become the first company to get US approval for an IDH inhibitor as a treatment for myelodysplastic syndromes (MDS) after its Tibsovo drug was cleared by the FDA for the blood cancer.